Statistics about Health, Pharma & Medtech in Japan
Statistics
- Number of medical device patent applications Japan 2008-2017
- Astellas Pharma's total assets FY 2013-2022
- Daiichi Sankyo's revenue FY 2013-2022
- Production value share of medical devices Japan 2018, by sub-therapeutic category
- Takeda Pharmaceutical's revenue breakdown FY 2022, by region
- Astellas Pharma's female manager rate FY 2014-2017
- Chugai pharmaceutical's sales share 2022, by disease area
- Otsuka Holdings' operating income FY 2013-2022
- Major drug manufacturers Japan 2017, by number of products
- Prescription drug market sales share of original drugs 2008-2019
- Terumo's revenue FY 2013-2022
- Terumo's revenue share FY 2022, by business segment
- Otsuka Holdings' factories number 2018, by location
- Terumo's R&D expenditure FY 2013-2022
- Number of approved generic medical devices Japan FY 2013-2022, by year of submission
- Fuji Pharma's net sales FY 2013-2022
- Number of newly approved medical devices Japan FY 2014-2022, by category
- Number of medical drug manufacturing plants Japan 2018, by employee size
- Industry revenue of “Dental instruments and apparatus“ in Japan 2012-2024
- Forecast: medical and dental instruments manufacturing revenue Japan 2008-2018
- Medical information systems market size Japan FY 2019-2024
- Pharmaceutical companies in Japan: Revenue and profit
- Sawai Group's R&D expenditure FY 2013-2022
- Takeda Pharmaceutical's net income FY 2013-2022
- Breakdown production sanitary materials Japan 2018, by product
- PACS and related devices market size Japan FY 2019-2025
- Chugai Pharmaceutical's R&D expenditure 2013-2022
- Industry revenue of “Dental materials“ in Japan 2012-2024
- Industry revenue of “Medical instruments electronic equipment“ in Japan 2012-2024
- Industry revenue of “X-ray equipment“ in Japan 2012-2024
- Olympus Corporation's revenue share FY 2023, by segment
- Quasi-drugs production plants in Japan 2016, by region
- Sysmex's number of employees FY 2013-2022
- Industry revenue of “Medical instruments and apparatus“ in Japan 2012-2024
- Nipro's medical-related net sales FY 2014-2023
- Astellas Pharma's net profit FY 2013-2022
- Number of approved new medical devices Japan FY 2013-2022, by year of submission
- Digital health market revenue in Japan 2019-2028, by segment
- Ono Pharmaceutical's number of employees FY 2013-2022
- CBD market size Japan 2021-2025, by type
- Market size of breast imaging Japan 2019-2026
- Female care and FemTech market size Japan 2019-2021
- Revenue of the digital health industry in Japan 2019-2028
- Towa Pharmaceutical's total assets FY 2012-2017
- Nipro's pharma packaging-related operating income 2013-2022
- Sysmex's sales share 2022, by business
- Device lag of new medical devices Japan FY 2011-2020
- Astellas Pharma's operating profit FY 2013-2022
- Otsuka Holdings' total employees FY 2013-2022
- Chugai Pharmaceutical's operating profit FY 2013-2022
- R&D spending of pharmaceutical companies in relation to sales Japan FY 2015-2022
- Value of imported pharmaceutical drugs to Japan 2022, by region
- Prescription drug market sales share of generics 2008-2019
- Sawai Group's sales revenue FY 2013-2022
- Takeda Pharmaceutical's number of employees FY 2013-2022
- Nipro's sales share FY 2023, by business
- Otsuka Holdings' revenue share FY 2022, by segment
- Terumo's net income FY 2012-2020
- Towa Pharmaceutical's employee numbers FY 2012-2017
- Takeda Pharmaceutical's key products' sales values FY 2022
- Awareness level of the word "FemTech" among women Japan 2023
- Major biopharma companies Japan FY 2022, by sales
- Net sales of leading generics makers Japan 2020
- Fuji Pharma's R&D costs FY 2013-2022
- Sysmex's total assets FY 2011-2020
- Takeda Pharmaceutical's sales revenue of products FY 2022
- Takeda Pharmaceutical's revenue in Asia FY 2018-2022
- Takeda Pharmaceutical's revenue in the U.S. FY 2018-2022
- Annual growth of the hospital devices and equipment market in Japan FY 2011-2020
- Astellas Pharma's female employee rate FY 2014-2017
- Intention of women to use FemTech products Japan 2023
- Olympus Corporation's number of employees FY 2014-2023
- Nichi-Iko's gross profit FY 2013-2022
- Most used type of FemTech services among women Japan 2022
- Takeda Pharmaceutical's revenue in Japan FY 2018-2022
- Share of women who have used FemTech services or products Japan 2023, by age
- Major drug manufacturers Japan FY 2020, by wholesalers' sales share
- Total prescription drug revenues in Japan from top 10 companies 2015
- Daiichi Sankyo's net income FY 2013-2022
- Takeda Pharmaceutical's R&D expenses FY 2018-2022
- Otsuka Holdings' total assets FY 2013-2022
- Forecast of economic impacts of FemTech market Japan 2025, by category
- Value of exported pharmaceutical drugs from Japan 2021, by geographic region
- Hair remedies production quantity in Japan 2016, by item
- Value medical device exports from Japan 2021, by region
- Share of women using FemTech services Japan 2022
- Takeda Pharmaceutical's R&D expenditure FY 2013-2022
- Fuji Pharma's sales distribution FY 2022, by therapeutic category
- Hair remedies production amount in Japan 2021, by item
- Hospital devices and equipment market size Japan FY 2011-2019
- Nipro's pharma packaging-related net sales FY 2014-2023
- Towa Pharmaceutical's profit FY 2012-2017
- Nipro's operating income 2013-2022
- Number of medical drug manufacturing plants Japan 2022, by production value
- Companies with the highest number of pharmaceutical patent applications Japan 2022
- Production value of antidiarrheals intestinal regulators Japan 2021, by agent
- Breakdown value imported drugs Japan 2021, by category
- Daiichi Sankyo's total assets FY 2012-2021
- Sysmex's R&D expenses FY 2013-2022
- Production volume antidiarrheals intestinal regulators Japan 2021, by agent